The utility of silent myocardial infarction on electrocardiogram as an ASCVD risk enhancer for primary prevention: The multi-ethnic study of atherosclerosis.

[1]  W. Ambrosius,et al.  Association of Silent Myocardial Infarction With Major Cardiovascular Events in Diabetes: The ACCORD Trial , 2020, Diabetes Care.

[2]  V. Gudnason,et al.  Association Between Unrecognized Myocardial Infarction and Cerebral Infarction on Magnetic Resonance Imaging. , 2019, JAMA neurology.

[3]  E. Soliman.  Electrocardiographic definition of silent myocardial infarction in population studies: A call to standardize the standards. , 2019, Journal of electrocardiology.

[4]  Daniel E Forman,et al.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.

[5]  Marc P. Bonaca,et al.  Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis of Cardiovascular Outcomes Trials , 2019, Circulation.

[6]  E. Soliman,et al.  Interrelationships Between American Heart Association's Life's Simple 7, ECG Silent Myocardial Infarction, and Cardiovascular Mortality , 2019, Journal of the American Heart Association.

[7]  A. Khera,et al.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. , 2019, Circulation.

[8]  R. Lehmann,et al.  Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier? , 2018, Cardiovascular Diabetology.

[9]  M. Sabatine.  PCSK9 inhibitors: clinical evidence and implementation , 2018, Nature Reviews Cardiology.

[10]  W. Rosamond,et al.  Silent Myocardial Infarction and Long-Term Risk of Heart Failure: The ARIC Study. , 2018, Journal of the American College of Cardiology.

[11]  Predictors of electrocardiographic abnormalities in type 1 Diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy , 2017, Journal of Endocrinological Investigation.

[12]  David Couper,et al.  Race and Sex Differences in the Incidence and Prognostic Significance of Silent Myocardial Infarction in the Atherosclerosis Risk in Communities (ARIC) Study , 2016, Circulation.

[13]  A. Baumbach,et al.  Role of 12 lead ECG Q-waves as a marker of myocardial infarction in the era of cardiac magnetic resonance , 2016, Journal of Cardiovascular Magnetic Resonance.

[14]  A. Sharrett,et al.  Diabetes Mellitus, Prediabetes, and Incidence of Subclinical Myocardial Damage , 2014, Circulation.

[15]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[16]  C. Gibson,et al.  Prevalence, consequences, and implications for clinical trials of unrecognized myocardial infarction. , 2013, The American journal of cardiology.

[17]  R. Holman,et al.  Prognostic Significance of Silent Myocardial Infarction in Newly Diagnosed Type 2 Diabetes Mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79 , 2013, Circulation.

[18]  S. Pedersen,et al.  Prognostic significance of electrocardiographic Q-waves in a low-risk population. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[19]  Is silent myocardial infarction more common in women with type 2 diabetes than in men? , 2012, Journal of diabetes and its complications.

[20]  P. Ponikowski,et al.  Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. , 2011, Journal of the American College of Cardiology.

[21]  Yves Cottin,et al.  Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature. , 2011, Archives of cardiovascular diseases.

[22]  Jeroen J. Bax,et al.  Which parameters on magnetic resonance imaging determine Q waves on the electrocardiogram? , 2005, The American journal of cardiology.

[23]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[24]  B. Chaitman,et al.  The novacode criteria for classification of ECG abnormalities and their clinically significant progression and regression , 1998 .

[25]  G. Thorgeirsson,et al.  Unrecognized Myocardial Infarction: Epidemiology, Clinical Characteristics, and the Prognostic Role of Angina Pectoris: The Reykjavik Study , 1995, Annals of Internal Medicine.

[26]  T. Dawber,et al.  The silent coronary: the frequency and clinical characteristics of unrecognized myocardial infarction in the Framingham study. , 1959, Annals of internal medicine.

[27]  J. Behrman,et al.  The so-called silent myocardial infarction. , 1949, American practitioner and digest of treatment.